Intubation tubes market seen reaching $4.94 billion by 2030

The global intubation tubes market is projected to grow from $3.13 billion in 2025 to $4.94 billion by 2030, according to The Business Research Company. Rising surgical volumes, critical care demand and a push for safer airway management are driving the forecast.

Why it matters: - Intubation tubes are central to airway management during surgery, mechanical ventilation and intensive care. - The market’s projected climb to $4.94 billion by 2030 points to sustained demand in hospitals, emergency care and critical care settings. - Growth also signals more spending on infection prevention and advanced airway devices as health systems try to reduce ventilator-associated complications.

What happened: - The Business Research Company forecast the intubation tubes market will rise from $3.13 billion in 2025 to $3.41 billion in 2026. - The firm projects the market will reach $4.94 billion by 2030, implying a 9.7% compound annual growth rate from 2026 to 2030. - The company issued the outlook from London on Aug. 13, 2026. - A free sample of the market report is available online. - The full market report is also available.

The details: - Intubation tubes are flexible medical tubes inserted into the trachea through the mouth or nose. - The tubes help secure an open airway, deliver oxygen and other gases, and remove carbon dioxide. - The market’s recent growth was driven by more surgical procedures, higher prevalence of respiratory diseases, more intensive care units, growth in emergency medical services and wider access to anesthesia services. - Future growth is expected to come from demand for minimally invasive ventilation methods, efforts to reduce ventilator-associated infections, expansion of critical care infrastructure, an aging population and greater use of advanced anesthesia techniques. - Key product trends include wider use of advanced airway management devices, more single-use sterile intubation tubes, increased use of reinforced and preformed tubes in complex surgeries, and a stronger focus on patient safety and infection prevention. - Emergency and critical care uses are also expanding. - North America held the largest global market share in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - Rising surgical admissions are a direct demand signal for airway devices because general anesthesia typically requires endotracheal intubation. - The company pointed to 778,500 surgical admissions from public hospital elective surgery waiting lists in Australia in 2023-24, a 5.8% increase from the prior year. - North America’s lead reflects advanced healthcare infrastructure, high surgical volumes and investment in critical care capacity. - The market’s shift toward single-use sterile products suggests infection control is becoming a bigger purchasing factor. - The report’s emphasis on dashboards, scoring tools and hotspot analysis shows the company is targeting buyers who want planning data, not just a size estimate.

What's next: - Market growth is expected to accelerate through 2030 as healthcare systems expand critical care capacity and adopt more advanced ventilation and anesthesia techniques. - Regional opportunities outside North America are likely to increase as access to healthcare and medical technology improves. - Providers and suppliers will likely focus more on infection prevention, patient safety and devices designed for complex procedures.

The bottom line: - Intubation tubes remain a basic but essential part of modern care, and the market is set for steady expansion as surgery, critical care and respiratory treatment needs rise.